Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2408Source: DataRank Database

Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy is a research paper published in Clinical Pharmacology & Therapeutics (2021). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Download PDF

Cite:

Linked data & code

refsnp nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 4.53)OA: bronzeTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

T. Mark Beasley ORCID,Michelle D. Amaral,Jerzy P. Szaflarski ORCID,Tyler E. Gaston ORCID,Leslie E. Grayson ORCID

Live enrichment

PubMed:34464454 PMC:PMC8530979 OpenAlex:https://openalex.org/W3197328649

NHGRI NIH HHS

Grant: T32 HG008961

NHLBI NIH HHS

Grant: K24 HL133373

National Institutes of Health

Grant: 2T32HG008961-06

UAB-HudsonAlpha Genomic Medicine Training Program

National Institutes of Health

Grant: 3T32NS095775-02S1

UAB Training Program In Neuroscience

National Institutes of Health

Grant: 5R25NS079188-02

UAB Research and Education Program in Neurology, Neurosurgery, and Neuropathology

National Institutes of Health

Grant: 5K24HL133373-03

Patient Oriented Research in Personalized Antithrombotic Therapy

National Institutes of Health

Grant: 5P50NS108675-02

Innate and Adaptive Immunity in Parkinson Disease

FWCI

4.53

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: CC BY NC

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2408

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cpt.2408

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2408

Fields of Study

Cannabis and Cannabinoid ResearchEpilepsy research and treatmentGenetics and Neurodevelopmental Disorders0301 basic medicine03 medical and health sciences

MeSH Terms

Drug Resistant EpilepsyAdolescentAdultAnticonvulsantsCannabidiolChildChild, PreschoolDiarrheaFemaleForecastingHumansMalePharmacogeneticsGenetic VariationTreatment OutcomeGene Regulatory NetworksYoung AdultCompassionate Use Trials

Keywords

CannabidiolPharmacogeneticsMedicineOdds ratioInternal medicineTolerabilityEpilepsyPharmacologyOncologyGenotypeBiologyGeneticsPsychiatryCannabisAdverse effectGeneAdultCompassionate Use TrialsDiarrheaMaleDrug Resistant EpilepsyAdolescentResearchGenetic VariationYoung AdultTreatment OutcomeChild, PreschoolHumansAnticonvulsantsFemaleGene Regulatory NetworksChildForecasting

Sustainable Development Goals

SDG 0: Good health and well-being